. Author manuscript; available in PMC: 2010 Sep 1.

Published in final edited form as: HIV Clin Trials. 2009 Sep–Oct;10(5):341. doi: 10.1310/hct1005-314

Table 1.

Baseline characteristics of all study subjects (n=154)

	N(%) or median (range)

Age (years)	47 (25-73)

Sex (male)	125 (81%)

Race:
White	71 (46%)
African American	65 (42%)
Other	18 (12%)

BMI (kg/m²)	25 (11-41)

Duration of HIV (years)	11 ( 0.1- 25)

Duration of NRTI therapy (months) n=143	91 (3-327)

Duration of thymidine NRTI therapy (months): n=143	64 (0-327)

Duration of NNRTI therapy (months) n=143	10 (0-302)

Duration of PI therapy (months) N=143	43 (0-200)

CD4+ cell count (cells/mm³)	569 (67-1819)

HIV-1 RNA < 50 copies/ mL	97 (68%)